IGM Biosciences, Inc

(NASDAQ:IGMS)

Latest On IGM Biosciences, Inc (IGMS):

Date/Time Type Description Signal Details
2023-05-12 18:49 ESTNewsIGM Biosciences GAAP EPS of -$1.33 beats by $0.01, revenue of $0.52M misses by $0.79MN/A
2023-04-01 06:26 ESTNewsIGM Biosciences, Inc. (IGMS) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 08:17 ESTNewsIGM Biosciences Looks Attractive Before Phase 2 ReadoutN/A
2023-01-17 16:02 ESTNewsIGM Biosciences starts phase 1 trial of antibody therapy for solid tumorsN/A
2022-11-03 20:55 ESTNewsIGM Biosciences GAAP EPS of -$1.32 beats by $0.13, revenue of $0.33M beats by $0.07MN/A
2022-08-29 23:22 ESTNewsIGM Biosciences started at BofA Securities with a buy on IgM antibody candidatesN/A
2022-08-09 15:54 ESTNewsIGM Biosciences GAAP EPS of -$1.33 misses by $0.93, revenue of $0.4MN/A
2022-05-09 23:36 ESTNewsIGM Biosciences GAAP EPS of -$1.53 beats by $0.15N/A
2022-03-30 12:23 ESTNewsIGM prices $200.0M stock offeringN/A
2022-03-29 18:13 ESTNewsIGM Biosciences GAAP EPS of -$1.50 beats by $0.04N/A
2022-03-29 18:13 ESTNewsSanofi partners with IGM Biosciences in a deal worth over $6 billionN/A
2022-03-29 18:13 ESTNewsIGM Biosciences announces proposed stock offeringN/A
2022-03-29 18:13 ESTNewsIGM stock soars 120% amid Q4 results, while Stifel calls Sanofi deal 'inflection point'N/A
2022-02-24 06:45 ESTNewsIGM Biosciences: Interesting Science, Poor Trial DataN/A
2022-02-10 01:16 ESTNewsIGM Biosciences updates on early-stage studies for intranasal COVID-19 therapyN/A
2021-12-16 19:58 ESTNewsIGM Bio extends losses as H.C. Wainwright trims target on data for cancer candidateN/A
2021-12-08 18:38 ESTNewsIGM Biosciences in pact with Bill & Melinda Gates Foundation for malaria studiesN/A
2021-11-23 14:38 ESTNewsIGM Biosciences (IGMS) Investor Presentation - SlideshowN/A
2021-11-04 22:29 ESTNewsIGM Biosciences EPS beats by $0.05N/A
2021-10-12 18:15 ESTNewsWarning: IGMS is at high risk of performing badlyN/A
2021-10-11 23:00 ESTNewsIGM Biosciences sets up two new business unitsN/A
2021-10-07 01:22 ESTNewsIGMS is at high risk of performing badlyN/A
2021-09-27 09:45 ESTNewsWarning: IGMS has been downgraded to Very BearishN/A
2021-09-22 17:02 ESTNewsWarning: IGMS has been downgraded to Very Bearish.N/A
2021-08-09 20:41 ESTNewsIGM Biosciences EPS beats by $0.04N/A
2021-08-09 20:41 ESTNewsIGM BioSciences files for $400M mixed shelf offeringN/A
2021-07-31 02:37 ESTNewsIGM Biosciences names former Gilead executive as new chief medical officerN/A
2021-07-22 15:26 ESTNewsIGM Bio's IgM antibody shows antiviral activity in COVID-19 in miceN/A
2021-05-07 01:07 ESTNewsIGM Biosciences EPS beats by $0.02N/A
2021-04-12 13:28 ESTNewsIGM Biosciences appoints new commercial chiefN/A
2021-03-31 14:02 ESTNewsIGM Biosciences, Inc. (IGMS) CEO Fred Schwarzer on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-30 18:32 ESTNewsIGM Biosciences EPS beats by $0.08N/A
2021-03-17 23:21 ESTAnalyst RatingThe Analyst Target Price has increased from $96 to $98.63.Buy
2021-03-17 15:48 ESTNewsIGM Biosciences names Lisa Decker as its first ever business chiefN/A
2021-03-08 09:51 ESTAnalyst RatingThe Analyst Target Price has increased from $95.3 to $96.Buy
2021-02-01 09:42 ESTAnalyst RatingThe Analyst Target Price has increased from $92.44 to $95.3.Neutral
2021-01-20 09:49 ESTAnalyst RatingThe Analyst Target Price has increased from $89.56 to $92.44.Neutral
2021-01-13 22:58 ESTNewsIGM Biosciences reports quick assets and provides business updatesN/A
2021-01-12 17:59 ESTNewsMedivir sells global rights of birinapant to IGM BiosciencesN/A
2021-01-06 09:57 ESTAnalyst RatingThe Analyst Target Price has increased from $87.89 to $89.56.Buy
2020-12-23 18:37 ESTAnalyst RatingThe Analyst Target Price has increased from $87.44 to $87.89.Buy
2020-12-22 14:27 ESTAnalyst RatingThe Analyst Target Price has increased from $83.78 to $87.44.Buy
2020-12-10 05:53 ESTNewsPowered by ASH successes, new biotech winners boost liquidityN/A
2020-12-09 11:49 ESTNewsIGM Bio prices upsized $200M public offeringN/A
2020-12-09 11:49 ESTNewsIGM Biosciences (IGMS) Presents At American Society of Hematology Meeting - SlideshowN/A
2020-12-08 14:34 ESTAnalyst RatingThe Analyst Target Price has increased from $82.33 to $83.78.Neutral
2020-12-07 18:37 ESTNewsIGM Biosciences stock jumps 19% after ASH presentation, Stifel lifts price targetN/A
2020-12-07 18:37 ESTNewsIGM Biosciences proposes public offeringN/A
2020-12-04 18:33 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 23:59 ESTFinancialsCompany financials have been released.Neutral

About IGM Biosciences, Inc (IGMS):

IGM Biosciences, Inc., a biotechnology company, engages in the research and development of Immunoglobulin M (IgM) antibodies for the treatment of cancer. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with B cell NHL and other B cell malignancies. It is also developing IGM-8444, an IgM antibody targeting Death Receptor 5 proteins; and IGM-7354, is a bispecific IgM antibody delivering interleukin-15 cytokines to PD-L1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. IGM Biosciences, Inc. has a collaboration with Atreca Inc. and BeiGene Ltd. to discover, develop, and manufacture novel IgM and IgA antibodies targeting SARS-CoV-2 for the potential treatment of COVID-19; and strategic research collaboration and license agreement with AbCellera to discover and develop IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

IGMS Quotes by TradingView

See Advanced Chart

General

  • Name IGM Biosciences, Inc
  • Symbol IGMS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 103
  • Fiscal Year EndDecember
  • IPO Date2019-09-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://igmbio.com
View More

Valuation

  • Trailing PE 6.4
  • Price/Book (Most Recent Quarter) 14.83
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.79
  • Return on Assets -19%
  • Return on Equity -32%
  • Earnings Per Share -$71.75
  • Revenue Per Share $0
  • Gross Profit -22649000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 2.97 billion
  • EBITDA -33062000
  • PE Ratio -1.57
  • Analyst Target Price $98.63
  • Book Value Per Share $8.35
View More

Share Statistics

  • Shares Outstanding 25.49 million
  • Shares Float 7.74 million
  • % Held by Insiders 4334%
  • % Held by Institutions 58.55%
  • Shares Short 2.14 million
  • Shares Short Prior Month 1.94 million
  • Short Ratio 12.63
  • Short % of Float 26%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • 52 Week High $127.11
  • 52 Week Low $40.84
  • 50 Day Moving Average 93.75
  • 200 Day Moving Average 77.67
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

IGM Biosciences, Inc (IGMS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

IGM Biosciences, Inc (IGMS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.66-$0.694.35%
2020-06-302020-08-06$N/A-$0.62-$0.653.88%
2020-03-312020-05-07$N/A-$0.58-$0.55-5.45%
2019-12-312020-03-26$N/A-$0.49-$0.43-13.29%
2019-09-302019-11-07$N/A-$2.41-$0.84-185.78%

IGM Biosciences, Inc (IGMS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A N/A 12.76 million 8.28 million
Income Before Tax N/A N/A N/A -14.82 million -10.17 million
Selling General Administrative N/A N/A N/A 3.17 million 2.39 million
Gross Profit N/A N/A N/A -9.28 million -4.32 million
Ebit N/A N/A N/A -15.94 million -9.31 million
Operating Income N/A N/A N/A -15.94 million -10.67 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A 9.28 million 4.32 million
Total Other Income Expense Net N/A N/A N/A 1.12 million 501000
Net Income From Continuing Operations N/A N/A N/A -14.82 million -10.17 million
Net Income Applicable to Common Shares -20.27 million -18.84 million -17.62 million -14.82 million -10.17 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A -143.73 million -58.36 million
Change to Liabilities 639000 478000 -1.38 million 1.31 million -766000
Total Cash Flow from Investing Activities 11.49 million -2.95 million 28.53 million -143.73 million -58.36 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A -1.99 million 224.65 million
Change to Operating Activities 943000 2.5 million 717000 582000 -5.81 million
Change in Cash N/A N/A N/A -157.79 million 150.91 million
Total Cash from Operating Activities -15.08 million -13.08 million -16.39 million -12.07 million -15.38 million
Depreciation N/A N/A N/A -1.02 million 1.36 million
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A -2 million -2.52 million
Change to Net Income 3.37 million 2.54 million 1.65 million 1.88 million 12000
Capital Expenditures N/A N/A N/A 600000 589000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A N/A 21.12 million 15.23 million
Total Stockholder Equity N/A N/A N/A 240.23 million 254.62 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A N/A N/A 261.35 million 269.86 million
Common Stock 307000 306000 305000 304000 304000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -163.94 million -143.67 million -124.83 million -107.21 million -92.39 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 486000 258000 258000 258000 N/A
Cash N/A N/A N/A 35.89 million 193.68 million
Total Current Liabilities 13.28 million N/A N/A 8.88 million 6.42 million
Other Stockholder Equity 113000 296000 205000 43000 29000
Property, Plant & Equipment 26.58 million 22.6 million 18.19 million 18.02 million 12.47 million
Total Current Assets 184.65 million N/A N/A 231.1 million 248.12 million
Long Term Investments N/A N/A N/A 11.97 million 9.27 million
Net Tangible Assets 188.18 million 206.95 million 224.01 million 240.23 million 254.62 million
Short Term Investments N/A N/A N/A 188.74 million 48.4 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 3.19 million N/A N/A 3.09 million 2.78 million

IGM Biosciences, Inc (IGMS) Chart:

IGM Biosciences, Inc (IGMS) News:

Below you will find a list of latest news for IGM Biosciences, Inc (IGMS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

IGM Biosciences, Inc (IGMS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-202.50.05CALL165 446210.57FALSE-0.05-0.5
2025-06-2050CALL0 26540.61FALSE00
2025-06-207.50CALL0 1502.66FALSE00
2025-06-20100CALL0 76766.01FALSE00
2025-06-2012.50CALL0 13803.37FALSE00
2025-06-20150CALL0 1832.84FALSE00
2025-06-2017.50CALL0 14857.1FALSE00
2025-06-20200CALL0 77877.65FALSE00
2025-06-2022.50CALL0 21895.44FALSE00
2025-06-20250CALL0 8911.11FALSE00
2025-06-20300CALL0 40937.7FALSE00
2025-06-20350CALL0 11567.48FALSE00
2025-06-202.50PUT0 6337.23TRUE00
2025-06-2050PUT0 0532.02TRUE00
2025-06-207.50PUT0 1392.09TRUE00
2025-06-20100PUT0 0440.43TRUE00
2025-06-2012.50PUT0 0477.46TRUE00
2025-06-20150PUT0 0507.6TRUE00
2025-06-2017.50PUT0 0533.03TRUE00
2025-06-20200PUT0 0690.8TRUE00
2025-06-2022.50PUT0 0804.35TRUE00
2025-06-20250PUT0 0728.33TRUE00
2025-06-20300PUT0 0622.84TRUE00
2025-06-20350PUT0 0649.02TRUE00
2025-07-182.50.1CALL10 0174.12FALSE0.10
2025-07-1850CALL0 0423.18FALSE00
2025-07-187.50CALL0 0474.18FALSE00
2025-07-182.50PUT0 0523.9TRUE00
2025-07-1850PUT0 0330.74TRUE00
2025-07-187.50PUT0 0272.28TRUE00
2025-09-192.50.14CALL20 142130.93FALSE0.140
2025-09-1950CALL0 1177.55FALSE00
2025-09-197.50CALL0 2314.82FALSE00
2025-09-192.50PUT0 1126.86TRUE00
2025-09-1950PUT0 0227.78TRUE00
2025-09-197.50PUT0 0320.51TRUE00
2025-12-192.50CALL0 0151.18FALSE00
2025-12-1950CALL0 00FALSE00
2025-12-197.50CALL0 10FALSE00
2025-12-192.50PUT0 0321.23TRUE00
2025-12-1950PUT0 0242.03TRUE00
2025-12-197.50PUT0 0208.54TRUE00

Latest IGMS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$13.77
Jun 13, 2022 7:59 PM EST37$13.77
Jun 13, 2022 7:59 PM EST23$13.77
Jun 13, 2022 7:59 PM EST1$13.78
Jun 13, 2022 7:59 PM EST18$13.76

IGM Biosciences, Inc (IGMS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-23PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1496323/000119312520176628/0001193125-20-176628-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920012640/0001104659-20-012640-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920043315/0001104659-20-043315-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920043316/0001104659-20-043316-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920081463/0001104659-20-081463-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920081464/0001104659-20-081464-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920102346/0001104659-20-102346-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920103551/0001104659-20-103551-index.htm
2020-09-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1496323/000110465920103558/0001104659-20-103558-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920112192/0001104659-20-112192-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000110465920112193/0001104659-20-112193-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000114420419045671/0001144204-19-045671-index.htm
2019-09-24SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1496323/000114420419045770/0001144204-19-045770-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312519250818/0001193125-19-250818-index.htm
2019-09-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1496323/000119312519258945/0001193125-19-258945-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312519287456/0001193125-19-287456-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312520086938/0001193125-20-086938-index.htm
2020-03-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1496323/000119312520087043/0001193125-20-087043-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312520136294/0001193125-20-136294-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312520167816/0001193125-20-167816-index.htm
2020-06-23PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1496323/000119312520176628/0001193125-20-176628-index.htm
2020-07-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1496323/000119312520187904/0001193125-20-187904-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312520208300/0001193125-20-208300-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312520211922/0001193125-20-211922-index.htm
2020-08-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1496323/000119312520223697/0001193125-20-223697-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1496323/000119312520286199/0001193125-20-286199-index.htm
2020-11-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1496323/000119312520286254/0001193125-20-286254-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050408/0001209191-19-050408-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050409/0001209191-19-050409-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050410/0001209191-19-050410-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050411/0001209191-19-050411-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050412/0001209191-19-050412-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050413/0001209191-19-050413-index.htm
2019-09-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050511/0001209191-19-050511-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050512/0001209191-19-050512-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119050920/0001209191-19-050920-index.htm
2019-10-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119051406/0001209191-19-051406-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/0001209191-19-060106-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007604/0001209191-20-007604-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007606/0001209191-20-007606-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007610/0001209191-20-007610-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007615/0001209191-20-007615-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007617/0001209191-20-007617-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007623/0001209191-20-007623-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007626/0001209191-20-007626-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007632/0001209191-20-007632-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007634/0001209191-20-007634-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120007637/0001209191-20-007637-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120023459/0001209191-20-023459-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120023460/0001209191-20-023460-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120023462/0001209191-20-023462-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120023472/0001209191-20-023472-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120030754/0001209191-20-030754-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120030760/0001209191-20-030760-index.htm
2020-05-283/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120032813/0001209191-20-032813-index.htm
2020-05-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120032815/0001209191-20-032815-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120035102/0001209191-20-035102-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120041277/0001209191-20-041277-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120041279/0001209191-20-041279-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120046609/0001209191-20-046609-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120048684/0001209191-20-048684-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120049505/0001209191-20-049505-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120049886/0001209191-20-049886-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120050354/0001209191-20-050354-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120051221/0001209191-20-051221-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120053824/0001209191-20-053824-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120053825/0001209191-20-053825-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120053897/0001209191-20-053897-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120053898/0001209191-20-053898-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120053899/0001209191-20-053899-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120053900/0001209191-20-053900-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000120919120057056/0001209191-20-057056-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1496323/000127417320000092/0001274173-20-000092-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1496323/000156459019041849/0001564590-19-041849-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1496323/000156459020013183/0001564590-20-013183-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1496323/000156459020017736/0001564590-20-017736-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1496323/000156459020022812/0001564590-20-022812-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1496323/000156459020037708/0001564590-20-037708-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1496323/000156459020050843/0001564590-20-050843-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000163859920000135/0001638599-20-000135-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000163859920000361/0001638599-20-000361-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000163859920000658/0001638599-20-000658-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000163859920000850/0001638599-20-000850-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000178588220000001/0001785882-20-000001-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1496323/000178644220000001/0001786442-20-000001-index.htm

IGM Biosciences, Inc (IGMS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of IGM Biosciences, Inc (IGMS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 4334%
Institutional Ownership: 5855%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-09M KATHLEEN BEHRENSDirectorBuy4,503.0025.61115,319.5810,000.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/0001209191-19-060106-index.htm
2020-05-15Bruce KeytChief Scientific OfficerBuy1,013.0013.6013,776.801,013.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120030760/0001209191-20-030760-index.htm
2019-09-18Jakob Haldor TopsoeDirectorBuy1,250,000.0016.0020,000,000.0010,289,453.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050413/0001209191-19-050413-index.htm
2020-11-04Daniel ShinYu ChenChief Medical OfficerSell605.0050.0030,250.00116,473.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120057056/0001209191-20-057056-index.htm
2020-08-27Daniel ShinYu ChenChief Medical OfficerSell605.0045.1327,301.23116,518.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120048684/0001209191-20-048684-index.htm
2020-09-08Daniel ShinYu ChenChief Medical OfficerSell602.0050.2030,220.40116,518.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120049886/0001209191-20-049886-index.htm
2020-09-18Daniel ShinYu ChenChief Medical OfficerSell609.0077.9147,447.19116,518.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120051221/0001209191-20-051221-index.htm
2020-10-02Daniel ShinYu ChenChief Medical OfficerSell1,830.0073.50134,505.00116,518.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053824/0001209191-20-053824-index.htm
2020-08-11Daniel ShinYu ChenChief Medical OfficerBuy950.001.391,320.50117,468.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120046609/0001209191-20-046609-index.htm
2020-09-01Daniel ShinYu ChenChief Medical OfficerBuy950.001.391,320.50117,468.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120049505/0001209191-20-049505-index.htm
2020-09-17Daniel ShinYu ChenChief Medical OfficerBuy950.001.391,320.50117,468.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120051221/0001209191-20-051221-index.htm
2020-11-02Daniel ShinYu ChenChief Medical OfficerBuy950.001.391,320.50117,468.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120057056/0001209191-20-057056-index.htm
2020-10-01Daniel ShinYu ChenChief Medical OfficerBuy2,850.001.393,961.50119,368.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053824/0001209191-20-053824-index.htm
2019-09-18Christina Teng TopsoeDirectorBuy1,250,000.0016.0020,000,000.001,250,000.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050412/0001209191-19-050412-index.htm
2019-09-18Topsoe Holding A/S Haldor10% Share HolderBuy1,250,000.0016.0020,000,000.001,250,000.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050409/0001209191-19-050409-index.htm
2020-04-01Michael Stewart LeeDirectorBuy178.00178.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920043316/0001104659-20-043316-index.htm
2020-10-01Bruce KeytChief Scientific OfficerSell1,000.0073.5973,590.001,896.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053825/0001209191-20-053825-index.htm
2020-05-15Fred SchwarzerCEO and PresidentBuy1,096.0013.6014,905.60197,814.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120030754/0001209191-20-030754-index.htm
2020-04-01BROS. ADVISORS LP BAKERDirectorBuy223.00261,019.00https://www.sec.gov/Archives/edgar/data/1496323/000163859920000361/0001638599-20-000361-index.htm
2020-07-01BROS. ADVISORS LP BAKERDirectorBuy223.00261,242.00https://www.sec.gov/Archives/edgar/data/1496323/000163859920000658/0001638599-20-000658-index.htm
2020-10-01BROS. ADVISORS LP BAKERDirectorBuy223.00261,465.00https://www.sec.gov/Archives/edgar/data/1496323/000163859920000850/0001638599-20-000850-index.htm
2020-05-15Bruce KeytChief Scientific OfficerBuy2,637.0013.6035,863.202,637.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120030760/0001209191-20-030760-index.htm
2020-04-01BROS. ADVISORS LP BAKERDirectorBuy223.002,883,427.00https://www.sec.gov/Archives/edgar/data/1496323/000163859920000361/0001638599-20-000361-index.htm
2020-07-01BROS. ADVISORS LP BAKERDirectorBuy223.002,883,650.00https://www.sec.gov/Archives/edgar/data/1496323/000163859920000658/0001638599-20-000658-index.htm
2020-10-01BROS. ADVISORS LP BAKERDirectorBuy223.002,883,873.00https://www.sec.gov/Archives/edgar/data/1496323/000163859920000850/0001638599-20-000850-index.htm
2020-09-10Bruce KeytChief Scientific OfficerSell1,000.0060.0060,000.002,896.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050354/0001209191-20-050354-index.htm
2019-09-20Redmile Group, LLCDirectorBuy3,144,000.0016.0050,304,000.003,144,000.00https://www.sec.gov/Archives/edgar/data/1496323/000114420419045671/0001144204-19-045671-index.htm
2020-04-01Redmile Group, LLCDirectorBuy178.003,144,178.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920043315/0001104659-20-043315-index.htm
2020-07-01Redmile Group, LLCDirectorBuy178.003,144,356.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920081463/0001104659-20-081463-index.htm
2020-09-01Redmile Group, LLCDirectorBuy41,759.0044.841,872,327.403,186,115.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920102346/0001104659-20-102346-index.htm
2020-09-02Redmile Group, LLCDirectorBuy1,464.0045.5466,674.223,187,579.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920102346/0001104659-20-102346-index.htm
2020-09-02Redmile Group, LLCDirectorBuy19,173.0046.76896,592.753,206,752.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920102346/0001104659-20-102346-index.htm
2020-09-03Redmile Group, LLCDirectorBuy74,253.0048.693,615,207.793,281,005.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920102346/0001104659-20-102346-index.htm
2020-09-04Redmile Group, LLCDirectorBuy74,433.0050.283,742,186.063,355,438.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920103551/0001104659-20-103551-index.htm
2020-09-08Redmile Group, LLCDirectorBuy47,113.0049.912,351,504.063,402,551.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920103551/0001104659-20-103551-index.htm
2020-09-09Redmile Group, LLCDirectorBuy14,610.0052.96773,811.353,417,161.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920103551/0001104659-20-103551-index.htm
2020-09-09Redmile Group, LLCDirectorBuy8,650.0051.85448,523.263,425,811.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920103551/0001104659-20-103551-index.htm
2020-10-01Redmile Group, LLCDirectorBuy178.003,425,989.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920112192/0001104659-20-112192-index.htm
2019-09-18Christina Teng TopsoeDirectorBuy34,375.0016.00550,000.0034,375.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050412/0001209191-19-050412-index.htm
2019-09-18Jakob Haldor TopsoeDirectorBuy34,375.0016.00550,000.0034,375.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050413/0001209191-19-050413-index.htm
2020-04-01Christina Teng TopsoeDirectorBuy357.0034,732.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120023460/0001209191-20-023460-index.htm
2020-07-01Christina Teng TopsoeDirectorBuy357.0035,089.00https://www.sec.gov/Archives/edgar/data/1496323/000178644220000001/0001786442-20-000001-index.htm
2019-09-18MICHAEL D LOBERGDirectorBuy5,000.0018.5792,867.0035,264.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050411/0001209191-19-050411-index.htm
2020-10-01Christina Teng TopsoeDirectorBuy357.0035,446.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053899/0001209191-20-053899-index.htm
2019-09-18Jakob Haldor TopsoeDirectorBuy1,100.0018.9820,881.0835,475.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050413/0001209191-19-050413-index.htm
2020-07-01Michael Stewart LeeDirectorBuy178.00356.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920081464/0001104659-20-081464-index.htm
2020-06-04Bruce KeytChief Scientific OfficerBuy2,837.001.393,943.433,850.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120035102/0001209191-20-035102-index.htm
2020-06-04Bruce KeytChief Scientific OfficerBuy150.0040.276,040.504,000.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120035102/0001209191-20-035102-index.htm
2020-04-01MICHAEL D LOBERGDirectorBuy535.0040,338.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120023459/0001209191-20-023459-index.htm
2019-09-18Julie HambletonDirectorBuy5,000.0018.3191,550.005,000.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050410/0001209191-19-050410-index.htm
2019-09-19Jakob Haldor TopsoeDirectorBuy14,340.0022.01315,610.4950,415.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050512/0001209191-19-050512-index.htm
2020-10-01Michael Stewart LeeDirectorBuy178.00534.00https://www.sec.gov/Archives/edgar/data/1496323/000110465920112193/0001104659-20-112193-index.htm
2020-07-01MICHAEL D LOBERGDirectorBuy535.00535.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120041277/0001209191-20-041277-index.htm
2020-10-01MICHAEL D LOBERGDirectorBuy535.00535.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053898/0001209191-20-053898-index.htm
2019-09-24Jakob Haldor TopsoeDirectorBuy4,000.0020.5081,994.0054,415.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050920/0001209191-19-050920-index.htm
2020-04-01Jakob Haldor TopsoeDirectorBuy178.0054,593.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120023462/0001209191-20-023462-index.htm
2020-07-01Jakob Haldor TopsoeDirectorBuy178.0054,771.00https://www.sec.gov/Archives/edgar/data/1496323/000178588220000001/0001785882-20-000001-index.htm
2020-10-01Jakob Haldor TopsoeDirectorBuy178.0054,949.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053900/0001209191-20-053900-index.htm
2019-12-09M KATHLEEN BEHRENSDirectorBuy5,497.0024.26133,338.535,497.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/0001209191-19-060106-index.htm
2019-09-18M KATHLEEN BEHRENSDirectorBuy62,500.0016.001,000,000.0062,500.00https://www.sec.gov/Archives/edgar/data/1496323/000120919119050408/0001209191-19-050408-index.htm
2020-04-01M KATHLEEN BEHRENSDirectorBuy357.0062,857.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120023472/0001209191-20-023472-index.htm
2020-07-01M KATHLEEN BEHRENSDirectorBuy357.0063,214.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120041279/0001209191-20-041279-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy978.0056.4155,165.0764,192.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy2,367.0057.75136,691.4166,559.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy5,132.0058.75301,511.1671,691.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy4,442.0059.65264,947.5376,133.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy5,033.0060.86306,332.5481,166.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy4,336.0061.80267,983.8885,502.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy2,791.0063.06176,003.5388,293.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy3,351.0063.58213,043.8591,644.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-09-10M KATHLEEN BEHRENSDirectorBuy1,570.0064.80101,728.9493,214.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/0001209191-20-050353-index.htm
2020-10-01M KATHLEEN BEHRENSDirectorBuy357.0093,571.00https://www.sec.gov/Archives/edgar/data/1496323/000120919120053897/0001209191-20-053897-index.htm